(Q44968643)

English

A phase I study of cantuzumab mertansine administered as a single intravenous infusion once weekly in patients with advanced solid tumors

scientific article published in July 2004

Statements

A phase I study of cantuzumab mertansine administered as a single intravenous infusion once weekly in patients with advanced solid tumors (English)
Paul R Helft
Richard L Schilsky
Frank J Hoke
Daphne Williams
Hedy L Kindler
Evie Sprague
Mark DeWitte
Helen K Martino
John Erickson
Lini Pandite
Mark Russo
John M Lambert
Maria Howard
4363-4368

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit